BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 26425675)

  • 1. Surrogate Prognostic Biomarkers in OSCC: The Paradigm of PA28γ Overexpression.
    Kontos CK
    EBioMedicine; 2015 Aug; 2(8):784-5. PubMed ID: 26425675
    [No Abstract]   [Full Text] [Related]  

  • 2. Associations between proteasomal activator PA28γ and outcome of oral squamous cell carcinoma: Evidence from cohort studies and functional analyses.
    Li J; Feng X; Sun C; Zeng X; Xie L; Xu H; Li T; Wang R; Xu X; Zhou X; Zhou M; Zhou Y; Dan H; Wang Z; Ji N; Deng P; Liao G; Geng N; Wang Y; Zhang D; Lin Y; Ye L; Liang X; Li L; Luo G; Jiang L; Wang Z; Chen Q
    EBioMedicine; 2015 Aug; 2(8):851-8. PubMed ID: 26425691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downexpression of Matriptase-2 Correlates With Tumor Progression and Clinical Prognosis in Oral Squamous-Cell Carcinoma.
    Cheng MF; Lin LH; Huang MS; Lee HS; Ji DD; Lin CS; Hsia KT
    Appl Immunohistochem Mol Morphol; 2017 Aug; 25(7):481-488. PubMed ID: 26862950
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Co-Expression of TWIST1 and ZEB2 in Oral Squamous Cell Carcinoma Is Associated with Poor Survival.
    Kong YH; Syed Zanaruddin SN; Lau SH; Ramanathan A; Kallarakkal TG; Vincent-Chong VK; Wan Mustafa WM; Abraham MT; Abdul Rahman ZA; Zain RB; Cheong SC
    PLoS One; 2015; 10(7):e0134045. PubMed ID: 26214683
    [TBL] [Abstract][Full Text] [Related]  

  • 5. EMMPRIN expression in oral squamous cell carcinomas: correlation with tumor proliferation and patient survival.
    Monteiro LS; Delgado ML; Ricardo S; Garcez F; do Amaral B; Pacheco JJ; Lopes C; Bousbaa H
    Biomed Res Int; 2014; 2014():905680. PubMed ID: 24967412
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Construction of an oral squamous cell carcinoma cell line for stable PA28γ overexpression].
    Xin C; Wang JK; Li J; Zeng X
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2020 Feb; 38(1):6-10. PubMed ID: 32037759
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PA28γ acts as a dual regulator of IL-6 and CCL2 and contributes to tumor angiogenesis in oral squamous cell carcinoma.
    Liu S; Liu D; Zeng X; Wang J; Liu J; Cheng J; Lei K; Bai H; Ji N; Zhou M; Jiang L; Dan H; Li J; Chen Q
    Cancer Lett; 2018 Aug; 428():192-200. PubMed ID: 29702196
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Caspase expression in oral squamous cell carcinoma.
    Coutinho-Camillo CM; Lourenço SV; Nishimoto IN; Kowalski LP; Soares FA
    Head Neck; 2011 Aug; 33(8):1191-8. PubMed ID: 21755562
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased Cdc7 expression is a marker of oral squamous cell carcinoma and overexpression of Cdc7 contributes to the resistance to DNA-damaging agents.
    Cheng AN; Jiang SS; Fan CC; Lo YK; Kuo CY; Chen CH; Liu YL; Lee CC; Chen WS; Huang TS; Wang TY; Lee AY
    Cancer Lett; 2013 Sep; 337(2):218-25. PubMed ID: 23684929
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Tissue and serum expression of TGM-3 may be prognostic marker in patients of oral squamous cell carcinoma undergoing chemo-radiotherapy.
    Nayak S; Bhatt MLB; Goel MM; Gupta S; Mahdi AA; Mishra A; Mehrotra D
    PLoS One; 2018; 13(6):e0199665. PubMed ID: 29953521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low miR-143/miR-145 Cluster Levels Induce Activin A Overexpression in Oral Squamous Cell Carcinomas, Which Contributes to Poor Prognosis.
    Bufalino A; Cervigne NK; de Oliveira CE; Fonseca FP; Rodrigues PC; Macedo CC; Sobral LM; Miguel MC; Lopes MA; Paes Leme AF; Lambert DW; Salo TA; Kowalski LP; Graner E; Coletta RD
    PLoS One; 2015; 10(8):e0136599. PubMed ID: 26317418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix metalloproteinase-2 and -9 activities correlate with the disease-free survival of oral squamous cell carcinoma patients.
    Yorioka CW; Coletta RD; Alves F; Nishimoto IN; Kowalski LP; Graner E
    Int J Oncol; 2002 Jan; 20(1):189-94. PubMed ID: 11743663
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of proteasomal activator PA28α serves as a prognostic factor in oral squamous cell carcinoma.
    Feng X; Jiang Y; Xie L; Jiang L; Li J; Sun C; Xu H; Wang R; Zhou M; Zhou Y; Dan H; Wang Z; Ji N; Deng P; Liao G; Geng N; Wang Y; Zhang D; Lin Y; Ye L; Liang X; Li L; Luo G; Feng M; Fang J; Zeng X; Wang Z; Chen Q
    J Exp Clin Cancer Res; 2016 Feb; 35():35. PubMed ID: 26892607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overexpression of p53 is an early event in the tumorigenesis of oral squamous cell carcinomas.
    Shintani S; Yoshihama Y; Emilio AR; Matsumura T
    Anticancer Res; 1995; 15(2):305-8. PubMed ID: 7762998
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated N-myristoyltransferase activity and expression in oral squamous cell carcinoma.
    Shrivastav A; Sharma AR; Bajaj G; Charavaryamath C; Ezzat W; Spafford P; Gore-Hickman R; Singh B; Copete MA; Sharma RK
    Oncol Rep; 2007 Jul; 18(1):93-7. PubMed ID: 17549352
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic factors of survival rate in oral squamous cell carcinoma: clinical, histologic, genetic and molecular concepts.
    Taghavi N; Yazdi I
    Arch Iran Med; 2015 May; 18(5):314-9. PubMed ID: 25959914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Osteopontin Involves Cisplatin Resistance and Poor Prognosis in Oral Squamous Cell Carcinoma.
    Luo SD; Chen YJ; Liu CT; Rau KM; Chen YC; Tsai HT; Chen CH; Chiu TJ
    Biomed Res Int; 2015; 2015():508587. PubMed ID: 26491674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Overexpression of BST2 is associated with nodal metastasis and poorer prognosis in oral cavity cancer.
    Fang KH; Kao HK; Chi LM; Liang Y; Liu SC; Hseuh C; Liao CT; Yen TC; Yu JS; Chang KP
    Laryngoscope; 2014 Sep; 124(9):E354-60. PubMed ID: 24706327
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Aurora B expression as a prognostic indicator and possible therapeutic target in oral squamous cell carcinoma.
    Pannone G; Hindi SA; Santoro A; Sanguedolce F; Rubini C; Cincione RI; De Maria S; Tortorella S; Rocchetti R; Cagiano S; Pedicillo C; Serpico R; Lo Muzio L; Bufo P
    Int J Immunopathol Pharmacol; 2011; 24(1):79-88. PubMed ID: 21496390
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical Expression of MCM-2 in Oral Epithelial Dysplasias.
    Zakaria SH; Farag HA; Khater DS
    Appl Immunohistochem Mol Morphol; 2018 Aug; 26(7):509-513. PubMed ID: 26990745
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.